190 related articles for article (PubMed ID: 12756158)
41. Paraoxonase and coronary heart disease.
Mackness MI; Mackness B; Durrington PN; Fogelman AM; Berliner J; Lusis AJ; Navab M; Shih D; Fonarow GC
Curr Opin Lipidol; 1998 Aug; 9(4):319-24. PubMed ID: 9739487
[TBL] [Abstract][Full Text] [Related]
42. Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Mackness B; Mackness M
Clin Biochem; 2019 Mar; 65():21-23. PubMed ID: 30659791
[TBL] [Abstract][Full Text] [Related]
43. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Marchesani M; Hakkarainen A; Tuomainen TP; Kaikkonen J; Pukkala E; Uimari P; Seppälä E; Matikainen M; Kallioniemi OP; Schleutker J; Lehtimäki T; Salonen JT
J Natl Cancer Inst; 2003 Jun; 95(11):812-8. PubMed ID: 12783936
[TBL] [Abstract][Full Text] [Related]
44. Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.
Han Y; Dorajoo R; Ke T; Ayala B; Chang X; Khor CC; van Dam RM; Yuan JM; Koh WP; Liu J; Goh DY; Friedlander Y; Heng CK
Atherosclerosis; 2015 May; 240(1):40-5. PubMed ID: 25746376
[TBL] [Abstract][Full Text] [Related]
45. Serum paraoxonase after myocardial infarction.
Ayub A; Mackness MI; Arrol S; Mackness B; Patel J; Durrington PN
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):330-5. PubMed ID: 9974415
[TBL] [Abstract][Full Text] [Related]
46. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
[TBL] [Abstract][Full Text] [Related]
47. Paraoxonase and coronary heart disease.
Mackness MI; Mackness B; Durrington PN
Atheroscler Suppl; 2002 Dec; 3(4):49-55. PubMed ID: 12573363
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Zapolski T
Med Sci Monit; 2014 Apr; 20():594-600. PubMed ID: 24721823
[TBL] [Abstract][Full Text] [Related]
49. Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis.
Suehiro T; Ikeda Y; Shiinoki T; Inoue M; Kumon Y; Itahara T; Hashimoto K
J Atheroscler Thromb; 2002; 9(3):133-8. PubMed ID: 12226554
[TBL] [Abstract][Full Text] [Related]
50. Novel serum paraoxonase activity assays are associated with coronary artery disease.
Martinelli N; Girelli D; Olivieri O; Guarini P; Bassi A; Trabetti E; Friso S; Pizzolo F; Bozzini C; Tenuti I; Annarumma L; Schiavon R; Franco Pignatti P; Corrocher R
Clin Chem Lab Med; 2009; 47(4):432-40. PubMed ID: 19275503
[TBL] [Abstract][Full Text] [Related]
51. Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Wysocka A; Cybulski M; P Wysokiński A; Berbeć H; Stążka J; Zapolski T
J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30935088
[TBL] [Abstract][Full Text] [Related]
52. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.
Ferré N; Camps J; Prats E; Vilella E; Paul A; Figuera L; Joven J
Clin Chem; 2002 Feb; 48(2):261-8. PubMed ID: 11805006
[TBL] [Abstract][Full Text] [Related]
53. Serum triglyceride concentration and coronary heart disease.
Schillaci G; Pirro M; Mannarino E
Circulation; 2002 Feb; 105(8):e54. PubMed ID: 11864938
[No Abstract] [Full Text] [Related]
54. Effect of statins on serum apolipoprotein j and paraoxonase-1 levels in patients with ischemic heart disease undergoing coronary angiography.
Poulakou MV; Paraskevas KI; Vlachos IS; Karabina SA; Wilson MR; Iliopoulos DC; Tsitsilonis SI; Mikhailidis DP; Perrea DN
Angiology; 2008; 59(2):137-44. PubMed ID: 18403458
[TBL] [Abstract][Full Text] [Related]
55. Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
Knekt P; Reunanen A; Alfthan G; Heliövaara M; Rissanen H; Marniemi J; Aromaa A
Arch Intern Med; 2001 Jul; 161(13):1589-94. PubMed ID: 11434790
[TBL] [Abstract][Full Text] [Related]
56. Prospective study of selenium levels in toenails and risk of coronary heart disease in men.
Yoshizawa K; Ascherio A; Morris JS; Stampfer MJ; Giovannucci E; Baskett CK; Willett WC; Rimm EB
Am J Epidemiol; 2003 Nov; 158(9):852-60. PubMed ID: 14585763
[TBL] [Abstract][Full Text] [Related]
57. Cautionary note on the use of pulse pressure as a risk factor for coronary heart disease.
Davidson KW; Pickering TG; Jonas BS
Circulation; 2001 Nov; 104(22):E128-9. PubMed ID: 11723040
[No Abstract] [Full Text] [Related]
58. [Is PON1 a factor of cardiovascular risk in type 2 diabetes?].
Triki S; Fekih O; Hellara I; Neffati F; Douki W; Ben Hamda K; Maatouk F; Najjar MF
Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):81-6. PubMed ID: 25813652
[TBL] [Abstract][Full Text] [Related]
59. Free protein S level as a risk factor for coronary heart disease and stroke in a prospective cohort study of healthy United Kingdom men.
Ken-Dror G; Cooper JA; Humphries SE; Drenos F; Ireland HA
Am J Epidemiol; 2011 Oct; 174(8):958-68. PubMed ID: 21911828
[TBL] [Abstract][Full Text] [Related]
60. Interleukin 18 and coronary heart disease: prospective study and systematic review.
Jefferis BJ; Papacosta O; Owen CG; Wannamethee SG; Humphries SE; Woodward M; Lennon LT; Thomson A; Welsh P; Rumley A; Lowe GD; Whincup PH
Atherosclerosis; 2011 Jul; 217(1):227-33. PubMed ID: 21481392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
